RyboDyn
Edit

RyboDyn

https://www.rybodyn.com/
Last activity: 25.07.2026
Active
Categories: AIBiotechCancerDeepTechDrugDiscoveryGenomicsHealthcareImmunotherapyOncologyProteomicsSequencingTherapeutics
Rybo Dynamics is in the relentless pursuit of front-running scientific breakthroughs that give labs all over the world the ability to develop revolutionary medicines that will create a healthier world for all and healthy life for you.
Mentions
11
Total raised: $14M

Investors 1

Funding Rounds 2

DateSeriesAmountInvestors
25.03.2026Seed$10MGenedant
12.01.2025Pre-Seed$4M-

Mentions in press and media 11

DateTitleDescription
25.07.2026US biotech company Rybodyn supported by Singapore’s AngelCentralAngelCentral, a Singapore-based investor, revealed on Wednesday that its members have successfully formed its first BioTech syndicate to invest in RyboDyn Inc., a US biotechnology business that is leading the way in the development of immun...
27.03.2026RyboDyn Secures $10M Seed Funding for AI-Powered Cancer Target DiscoveryBiotech firm RyboDyn landed $10 million in seed funding. The San Diego company pioneers an AI-driven platform. It decodes the "dark proteome." This unlocks hidden cancer targets. Traditional methods miss these crucial markers. The...
25.03.2026RyboDyn: $10 Million Seed Funding Raised For AI-Powered Cancer Target DiscoveryRyboDyn, a biotechnology company focused on decoding the dark proteome to uncover new cancer targets, announced the initial close of a $10 million seed financing round. The company said the funding will support its transition from foundatio...
24.03.2026RyboDyn Raises $10M in Seed FundingRyboDyn, Inc., a San Diego, CA-based biotechnology company providing an AI-powered sequencing and discovery platform, raised $10M in Seed funding. Backers were not disclosed. The company intends to use the funds to expand operations and its...
11.08.2025SeaX: Interview With Founder & CEO Kid Parchariyanon About The Early-Stage Investment FirmSoutheast Asia Exponential Ventures (SeaX) is a VC fund investing globally in early-stage companies with game-changing “exponential” technologies. Pulse 2.0 interviewed SeaX founder and CEO Kid Parchariyanon to gain a deeper understanding o...
14.01.2025RyboDyn: Unveiling the Dark Genome with $4 Million in Pre-Seed FundingIn the world of biotechnology, innovation is the lifeblood. RyboDyn, a San Diego-based company, has just taken a bold step forward. With $4 million in pre-seed funding, they aim to illuminate the dark corners of the human genome. This fundi...
12.01.2025RyboDyn: $4 Million (Pre-Seed) Raised To Pioneer Development Of First-In-Class ImmunotherapiesRyboDyn announced the discovery of a new proteome and the successful closing of a $4 million pre-seed financing round to advance its mission of targeting the dark proteome to develop novel immunotherapies. The funding round was co-led by Ge...
09.01.2025RyboDyn Raises $4M in Pre-Seed FundingRyboDyn, a San Diego, CA-based biotechnology company developing immunotherapies targeting the dark genome, raised $4M in Pre-Seed funding. The round was led by Genedant Capital and SeaX Ventures, with participation from SOSV and Swell VC. T...
09.01.2025RyboDyn Announces $4M Pre-Seed Financing SAN DIEGO, CA, RyboDyn has announced the discovery of a new proteome and the successful closing of a $4 million pre-seed financing round. >> Click here for more funding data on RyboDyn >> To export RyboDyn funding data to PDF a...
-Rybodyn“Rybo Dynamics is in the relentless pursuit of front-running scientific breakthroughs that give labs all over the world the ability to develop revolutionary medicines that will create a healthier world for all and healthy life for you. ”...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In